The dangers of atypical mole (dysplastic nevus) syndrome: Teaching at- risk patients to protect themselves from melanoma

Postgraduate Medicine

Volumn 105, Issue 7, 1999, Pages 147-164

  Marghoob, Ashfaq A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RISK; CLINICAL FEATURE; DYSPLASTIC NEVUS; EARLY DIAGNOSIS; HIGH RISK POPULATION; INHERITANCE; MELANOMA; PATIENT EDUCATION; PREVALENCE; REVIEW; RISK FACTOR; SKIN CARCINOGENESIS; SKIN EXAMINATION;

DYSPLASTIC NEVUS SYNDROME; HUMANS; MELANOMA; PATIENT EDUCATION; RISK FACTORS; SELF-EXAMINATION; SKIN; SKIN NEOPLASMS;

EID: 0033026822     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Rigel DS, Friedman RJ, Kopf AW. The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol 1996; 34(5 Pt 1):839-47
2. American Cancer Society. Cancer facts and figures - 1997. Publication 97-300M No. 5008.97
3. Salopek TG, Marghoob AA, Slade JM, et al. An estimate of the incidence of malignant melanoma in the United States: based on a survey of members of the American Academy of Dermatology. Dermatol Surg 1995;21(4):301-5
4. Slade J, Marghoob AA, Salopek TG, et al. A typical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management. J Am Acad Dermatol 1995;32(3):479-94
5. Robinson JK. A 28-year-old fair-skinned woman with multiple moles (clinical conference). JAMA 1997;278(20):1693-9 [Erratum, JAMA 1998;279(11):838]
6. Kruger S, Garbe C, Buttner P, et al. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma: results of a case control study in melanoma patients and nonmelanoma control subjects. J Am Acad Dermatol 1992; 26(6):920-6
7. Marghoob AA. Clinical crossroads: a young light-skinned woman with multiple moles. (Letter) JAMA 1998;279(11):838
8. Marghoob AA. Basal and squamous cell carcinomas: what every primary care physician should know. Postgrad Med 1997; 102(2):139-59
9. Screening for skin cancer. In: Guide to clinical preventive services: report of the US Preventive Services Task Force. 2d ed. Baltimore: Williams & Wilkins, 1996:141-52
10. Greene MH. Genetics of cutaneous melanoma and nevi. Mayo Clin Proc 1997; 72(5):467-74
11. Abadir MC, Marghoob AA, Slade J, et al. Case-control study of melanocytic nevi on the buttocks in atypical mole syndrome: role of solar radiation in the pathogenesis of atypical moles. J Am Acad Dermatol 1995;33(1):31-6
12. Marghoob AA, Kopf AW, Rigel DS, et al. Risk of cutaneous malignant melanoma in patients with "classic" atypical-mole syndrome: a case-control study. Arch Dermatoi 1994;130(8):993-8
13. Marghoob AA, Slade J, Kopf AW, et al. Risk of developing multiple primary cutaneous melanomas in patients with the classic atypical-mole syndrome: a case-control study. Br J Dermatol 1996;135(5): 704-11
14. Whited JD, Grichnik JM. Does this patient have a mole or a melanoma? JAMA 1998;279(9):696-701
15. Masri GD, Clark WH Jr, Guerry D 4th, et al. Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol 1990;22(6 Pt 1):1042-8
16. Berwick M, Begg CB, Fine JA, et al. Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst 1996; 88(1): 17-23
17. Novakovic B, Clark WH Jr, Fears TR, et al. Melanocytic nevi, dysplastic nevi, and malignant melanoma in children from melanoma-prone families. J Am Acad Dermatol 1995;33(4):631-6
18. Kelly JW, Yeatman JM, Regalia C, et al. A high incidence of melanoma found in patients with multiple dysplastic naevi by photographic surveillance. Med J Aust 1997;167(4):191-4
19. Chabner BA, Haluska FG, Talcott JA. Screening strategies for cancer: implications and results. (Editorial) JAMA 1997;277(18):1475-6
20. Rao BK, Marghoob AA, Stolz W, et al. Can early malignant melanoma be differentiated from atypical melanocytic nevi by in vivo techniques? Part I. Clinical and dermoscopic characteristics. Skin Res Technol 1997;3(1):8-14
21. Grin JM, Grant-Kels JM, Grin CM, et al. Ocular melanomas and melanocytic lesions of the eye. J Am Acad Dermatol 1998;38(5 Pt 1):716-30
22. Naylor MF, Farmer KC. The case for sunscreens: a review of their use in preventing actinic damage and neoplasia. Arch Dermatol 1997;133(9):1146-54
23. Glanz K, Chang L, Song V, et al. Skin cancer prevention for children, parents, and caregivers: a field test of Hawaii's SunSmart program. J Am Acad Dermatol 1998;38(3):413-7